This combined 46.11% share is distributed directly to certain localities as follows:[1]
6.68% to Nassau County[2]
8.63% to Suffolk County[3]
10.8% to all participating counties (âDirect Share Subdivisionsâ) except Nassau and Suffolk according to the percentages in of New Yorkâs state-local agreement,[4] with non-participating countiesâ amounts reallocated amongst participating counties[5]
20% to New York City[6]
With limited exceptions,[7] the local share is restricted to spending on approved uses.[8] New York defines approved uses to mean âany opioid or substance use disorder related projects or programs that fall within the list of uses in .â[9] of New Yorkâs state-local agreement is similar to the national settlement agreementsâ (non-exhaustive) âs approved uses list and includes treatment, prevention, harm reduction, recovery supports, and other strategies.[10] The may recommend additions to or deletions from the list of approved uses to the legislature and governor.[11]
Notably, half of the 10.8% of funds going to the âDirect Share Subdivisionsâ (i.e., counties other than Suffolk and Nassau) are unrestricted funds that are not required to be spent on approved uses.[12]
Local governments decide autonomously (but must certify proper uses). The participating counties, Nassau and Suffolk counties, and New York City will ultimately decide for themselves how to spend their monies on abatement projects and programs,[13] but each must also annually certify to the (OASAS) and the that their shares were expended on approved uses.[14] This certification requirement does not apply to countiesâ unrestricted 5.4% share.[15]
A from the New York City Department of Health and Mental Hygiene provides examples of the cityâs independent abatement efforts.[16]
No, supplantation is not prohibited. New York does not explicitly prohibit supplantation uses of opioid settlement funds from the 46.11% local share. This means that the local share may be spent in ways that replace (or âsupplantâ) â rather than supplement â existing resources.
Up to each locality (no public reporting required, only some intrastate). The counties and New York City must provide a detailed accounting of their spending to each year to OASAS and the Advisory Board,[17] but New Yorkâs agreement does not require publication of these reports online. (This requirement does not apply to the unrestricted half of the funds going to the Direct Share Subdivisions, i.e., counties other than Suffolk and Nassau.) New York City has voluntarily published its report.
Visit OpioidSettlementTracker.comâs for an updated collection of statesâ and localitiesâ available expenditure reports.
Not applicable.
. â
. â
. â
(âto the Direct Share Subdivisionsâ),
(defining âDirect Share Subdivisionâ to mean âevery county of the State of New York other than the County of Nassau, the County of Suffolk, and the City of New Yorkâ), and
(âThe Direct Unrestricted Funds and the Direct Restricted Funds shall be paid to the Direct Share Subdivisions that execute a release for a given Statewide Opioid Settlement Agreement, pursuant to Section II.B.4 and 5, and will be fully distributed among them pursuant to the allocation set forth in Schedule A to this Agreementâ). â
. â
. â
(âAttorneysâ fees and expenses will be determined and paid according to each Direct Share Subdivisionâs and New York Subdivisionâs contracts with its respective counsel. This does not prevent counsel for New York subdivisions to agree to recover solely from: (1) the common benefit and contingency fee funds if established pursuant to settlements with Opioid Supply Chain Participants; or (2) payment of attorneysâ fees and costs directly from Opioid Supply Chain Participantsâ). â
(6.68% to Nassau County âfor spending on Approved Usesâ), (8.63% to Suffolk County âfor spending on Approved Usesâ), (requiring participating counties to spend of half of their amounts, their âDirect Restricted Fundsâ (5.4%), on approved uses), and (20% to New York City âfor spending on Approved Usesâ). â
. â
I.SS (âExhibit E provides a non-exhaustive list of expenditures that qualify as being paid for Opioid Remediation. Qualifying expenditures may include reasonable related administrative expensesâ). New Yorkâs adds a âPost-Mortemâ section to its âOther Strategiesâ category that includes approved uses like autopsies and synthetic opioid toxicology tests. . â
But may only recommend deletions with approval from ž of present Board members. . â
Compare (â5.4% to the Direct Share Subdivisions as âDirect Unrestricted Fundsââ) with (â5.4% to the Direct Share Subdivisions for spending on Approved Usesâ). â
Agreement (describing direct payments) and (describing localities as deciding their own spending on âprojects and programs that constitute Approved Usesâ). â
(âThese certifications shall be made by August 1 of each year following the year in which such funds were spent and shall be accompanied by a detailed accounting of the spending of such funds as well as analysis and evaluation of the projects and programs they have fundedâ). â
Compare (â5.4% to the Direct Share Subdivisions as âDirect Unrestricted Fundsââ) with ) (â5.4% to the Direct Share Subdivisions for spending on Approved Usesâ). The certification requirement applies to funds distributed to local governments pursuant to sections II.B(5)-(8) of the Agreement. . â
. NYC Department of Health and Mental Hygiene. March 2024. Accessed August 12, 2024. See also . Office of the New York Mayor. September 10, 2024. Accessed September 10, 2024. â
. â
What can this share be spent on?
Who ultimately decides how to spend this share (and how)?
Is this share attached to an explicit bar against supplantation?